We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current AMGN34 market cap is 30.42B. The company's latest EPS is USD 12.5510 and P/E is 24.37.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.11B | 6.99B | 6.9B | 8.2B | 7.45B |
| Operating Income | 3.79B | 2.68B | 2.02B | 2.73B | 1.59B |
| Net Income | 2.84B | 1.38B | 1.73B | 767M | -113M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 23.36B | 25.42B | 25.98B | 26.32B | 28.19B |
| Operating Income | 9.67B | 9.14B | 7.64B | 9.57B | 9.35B |
| Net Income | 7.84B | 7.26B | 5.89B | 6.55B | 6.72B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 88.72B | 90.27B | 90.53B | 97.15B | 92.98B |
| Total Liabilities | 83.37B | 83.49B | 82.88B | 90.92B | 87.96B |
| Total Equity | 5.35B | 6.78B | 7.66B | 6.23B | 5.02B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 59.71B | 62.95B | 61.17B | 65.12B | 97.15B |
| Total Liabilities | 50.03B | 53.54B | 54.47B | 61.46B | 90.92B |
| Total Equity | 9.67B | 9.41B | 6.7B | 3.66B | 6.23B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.06B | 5.17B | 7.93B | 8.47B | 689M |
| Investing | 1.36B | 1.15B | 885M | -26.2B | -217M |
| Financing | 21.51B | 20.3B | 18.29B | 21.05B | -1.71B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 9.15B | 10.5B | 9.26B | 9.72B | 8.47B |
| Investing | 5.71B | -5.4B | 733M | -6.04B | -26.2B |
| Financing | -15.77B | -4.87B | -8.27B | -4.04B | 21.05B |
| Market Cap | 30.42B |
| Price to Earnings Ratio | 24.37 |
| Price to Sales Ratio | 5.81 |
| Price to Cash Ratio | 14.96 |
| Price to Book Ratio | 26.27 |
| Dividend Yield | - |
| Shares Outstanding | 535.18M |
| Average Volume (1 week) | 1.01k |
| Average Volume (1 Month) | 2.4k |
| 52 Week Change | 42.28% |
| 52 Week High | 58.36 |
| 52 Week Low | 37.52 |
| Spread (Intraday) | 0.26 (0.45%) |
| Company Name | AMGEN Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.amgen.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
